Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alimera Sciences Re-Files for IPO
Private Equity Hub
Sunday, November 1, 2009 - 9:33am
tags:
Alimera
Tianyin Pharma Forms JV to Expand Antibiotics Business
Seeking Alpha
Sunday, November 1, 2009 - 9:32am
tags:
Tianyin Pharmaceutical, antibiotics
Biotech Tribulations Roundup: Failed Trials, Missed Targets, Business Mishaps
Seeking Alpha
Sunday, November 1, 2009 - 9:30am
tags:
biotech
Lilly Hopes New San Diego Facility Will Be 'a Biotechnology Powerhouse'
Seeking Alpha
Sunday, November 1, 2009 - 9:29am
tags:
Eli Lilly
Biotechs buck ‘green’ retreat
Boston Herald
Sunday, November 1, 2009 - 9:24am
tags:
AstraZeneca, biotech
BARACLUDE® (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
Yahoo/Business Wire
Sunday, November 1, 2009 - 9:11am
tags:
Baraclude, Adefovir, hepatitis B
Vertex Hep C Drug Cures 80% at New Dose: Study
The Street
Sunday, November 1, 2009 - 9:06am
tags:
Vertex Pharmaceuticals, Telaprevir, hepatitis C
Gilead Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread® For Chronic Hepatitis B
Yahoo/Business Wire
Sunday, November 1, 2009 - 9:04am
tags:
Viread, Gilead Sciences, hepatitis B
Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C
Yahoo/Business Wire
Sunday, November 1, 2009 - 9:03am
tags:
Bristol-Myers Squibb, ZymoGenetics, hepatitis C
Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting
Yahoo/AP
Sunday, November 1, 2009 - 9:00am
tags:
fidaxomicin, Optimer, Clostridium Difficile
Sanofi-aventis Delivers a Solid Performance in Third Quarter 2009
Fierce Biotech
Saturday, October 31, 2009 - 12:03pm
tags:
Sanofi
Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia
PR-USA.net
Saturday, October 31, 2009 - 12:02pm
tags:
Astellas, Theravance, pneumonia
AcelRx Announces Successful Completion Of End-of-Phase 2 Meeting On ARX-01, Sufentanil NanoTab PCA System For Post-Operative Pain Management
Medical News Today
Saturday, October 31, 2009 - 11:59am
tags:
Sufentanil NanoTab PCA System, AcelRx, pain management
Alexion Pharmaceuticals Inc. Leads Tech Top 40 Listings (in Connecticut)
Hartford Courant
Saturday, October 31, 2009 - 11:56am
tags:
Alexion
US FDA seeks more data from Transcept's insomnia drug Intermezzo
Pharmbiz
Saturday, October 31, 2009 - 11:53am
tags:
Transcept, Intermezzo
SemBioSys enters in non-dilutive financing plan of arrangement
CNW Telbec
Saturday, October 31, 2009 - 11:49am
tags:
SemBioSys
Valeant to Acquire Polish Products
PR NewsWire
Saturday, October 31, 2009 - 11:44am
tags:
Valeant Pharmaceuticals
Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
PR NewsWire
Saturday, October 31, 2009 - 11:39am
tags:
Eisai, Eribulin, breast cancer
Gilead: Transforming AIDS
Forbes
Saturday, October 31, 2009 - 10:55am
tags:
Gilead Sciences, AIDS
Abbott suing Impax Labs over generic TriCor
Yahoo/AP
Saturday, October 31, 2009 - 10:54am
tags:
Abbott Laboratories, Impax, TriCor

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.